ATSDR Minimal Risk Levels (MRLs) - August 2022 |
Route |
Duration |
MRL |
Factors* |
Endpoint |
Draft/ Final |
Cover Date |
CAS Number |
|
ACENAPHTHENE |
Oral |
Int. |
0.6 mg/kg/day |
300 |
Hepatic |
Final |
08/1995 |
83-32-9 |
|
ACETONE |
Inh. |
Acute |
8 ppm |
30 |
Neurol. |
Final |
06/2022 |
67-64-1 |
Oral |
Int. |
0.6 mg/kg/day |
100 |
Hemato. |
Final |
06/2022 |
67-64-1 |
|
ACROLEIN |
Inh. |
Acute |
0.003 ppm |
100 |
Resp. |
Final |
08/2007 |
107-02-8 |
Inh. |
Int. |
0.00004 ppm |
300 |
Resp. |
Final |
08/2007 |
107-02-8 |
Oral |
Int. |
0.004 mg/kg/day |
100 |
Gastro. |
Final |
08/2007 |
107-02-8 |
|
ACRYLAMIDE |
Oral |
Acute |
0.01 mg/kg/day |
30 |
Repro. |
Final |
12/2012 |
79-06-1 |
Oral |
Int. |
0.001 mg/kg/day |
30 |
Neurol. |
Final |
12/2012 |
79-06-1 |
Oral |
Chr. |
0.001 mg/kg/day |
30 |
Neurol. |
Final |
12/2012 |
79-06-1 |
|
ACRYLONITRILE |
Inh. |
Acute |
0.1 ppm |
10 |
Neurol. |
Final |
12/1990 |
107-13-1 |
Oral |
Acute |
0.1 mg/kg/day |
100 |
Develop. |
Final |
12/1990 |
107-13-1 |
Oral |
Int. |
0.01 mg/kg/day |
1000 |
Repro. |
Final |
12/1990 |
107-13-1 |
Oral |
Chr. |
0.04 mg/kg/day |
100 |
Hemato. |
Final |
12/1990 |
107-13-1 |
|
ALDRIN |
Oral |
Acute |
2 ug/kg/day |
1000 |
Develop. |
Final |
06/2022 |
309-00-2 |
Oral |
Chr. |
0.04 ug/kg/day |
1000 |
Hepatic |
Final |
06/2022 |
309-00-2 |
|
ALUMINUM |
Oral |
Int. |
1 mg/kg/day |
30 |
Neurol. |
Final |
09/2008 |
7429-90-5 |
Oral |
Chr. |
1 mg/kg/day |
90 |
Neurol. |
Final |
09/2008 |
7429-90-5 |
|
AMERICIUM |
Rad. |
Acute |
4 mSv |
3 |
Develop. |
Final |
04/2004 |
7440-35-9 |
Rad. |
Chr. |
1 mSv/yr |
3 |
Other |
Final |
04/2004 |
7440-35-9 |
|
AMMONIA |
Inh. |
Acute |
1.7 ppm |
30 |
Resp. |
Final |
09/2004 |
7664-41-7 |
Inh. |
Chr. |
0.1 ppm |
30 |
Resp. |
Final |
09/2004 |
7664-41-7 |
|
ANTHRACENE |
Oral |
Int. |
10 mg/kg/day |
100 |
Hepatic |
Final |
08/1995 |
120-12-7 |
|
ANTIMONY |
Inh |
Acute |
0.001 mg/m3 |
30 |
Resp. |
Final |
10/2019 |
7440-36-0 |
Inh. |
Int. |
0.001 mg/m3 |
30 |
Resp. |
Final |
10/2019 |
7440-36-0 |
Inh. |
Chr. |
0.0003 mg/m3 |
30 |
Resp. |
Final |
10/2019 |
7440-36-0 |
Oral |
Acute |
1 mg/kg/day |
100 |
Hepatic |
Final |
10/2019 |
7440-36-0 |
Oral |
Int. |
0.0006 mg/kg/day |
100 |
Metab. |
Final |
10/2019 |
7440-36-0 |
|
ARSENIC |
Oral |
Acute |
0.005 mg/kg/day |
10 |
Gastro. |
Final |
08/2007 |
7440-38-2 |
Oral |
Chr. |
0.0003 mg/kg/day |
3 |
Dermal |
Final |
08/2007 |
7440-38-2 |
|
ATRAZINE |
Oral |
Acute |
0.01 mg/kg/day |
100 |
Body Wt. |
Final |
09/2003 |
1912-24-9 |
Oral |
Int. |
0.003 mg/kg/day |
300 |
Repro. |
Final |
09/2003 |
1912-24-9 |
|
1-BROMOPROPANE |
Inh. |
Acute |
1 ppm |
30 |
Neurol. |
Final |
08/2017 |
106-94-5 |
Inh. |
Int. |
0.1 ppm |
30 |
Neurol. |
Final |
08/2017 |
106-94-5 |
Inh. |
Chr. |
0.02 ppm |
30 |
Neurol. |
Final |
08/2017 |
106-94-5 |
Oral |
Acute |
0.2 mg/kg/day |
100 |
Neurol. |
Final |
08/2017 |
106-94-5 |
|
2-BUTANONE |
Inh. |
Acute |
1 ppm |
100 |
Neurol. |
Final |
10/2020 |
78-93-3 |
|
2-BUTOXYETHANOL |
Inh. |
Acute |
6 ppm |
9 |
Hemato. |
Final |
08/1998 |
111-76-2 |
Inh. |
Int. |
3 ppm |
9 |
Hemato. |
Final |
08/1998 |
111-76-2 |
Inh. |
Chr. |
0.2 ppm |
3 |
Hemato. |
Final |
08/1998 |
111-76-2 |
Oral |
Acute |
0.4 mg/kg/day |
90 |
Hemato. |
Final |
08/1998 |
111-76-2 |
Oral |
Int. |
0.07 mg/kg/day |
1000 |
Hepatic |
Final |
08/1998 |
111-76-2 |
|
BARIUM, SOLUBLE SALTS |
Oral |
Int. |
0.2 mg/kg/day |
300 |
Renal |
Final |
08/2007 |
7440-39-3 |
Oral |
Chr. |
0.2 mg/kg/day |
300 |
Renal |
Final |
08/2007 |
7440-39-3 |
|
BENZENE |
Inh. |
Acute |
0.009 ppm |
300 |
Immuno. |
Final |
08/2007 |
71-43-2 |
Inh. |
Int. |
0.006 ppm |
300 |
Immuno. |
Final |
08/2007 |
71-43-2 |
Inh. |
Chr. |
0.003 ppm |
10 |
Immuno. |
Final |
08/2007 |
71-43-2 |
Oral |
Chr. |
0.0005 mg/kg/day |
30 |
Immuno. |
Final |
08/2007 |
71-43-2 |
|
BERYLLIUM |
Inh. |
Int. |
1 ng/m3 |
30 |
Resp. |
Draft |
01/2022 |
7440-41-7 |
|
BIS(2 CHLOROETHYL)ETHER (BCEE) |
Inh. |
Int. |
0.02 ppm |
1000 |
Body Wt. |
Final |
10/2017 |
111-44-4 |
|
BIS(CHLOROMETHYL)ETHER (BCME) |
Inh. |
Int. |
0.0003 ppm |
100 |
Resp. |
Final |
11/2017 |
542-88-1 |
|
BORON AND COMPOUNDS |
Inh. |
Acute |
0.3 mg/m3 |
3 |
Resp. |
Final |
11/2010 |
7440-42-8 |
Oral |
Acute |
0.2 mg/kg/day |
100 |
Develop. |
Final |
11/2010 |
7440-42-8 |
Oral |
Int. |
0.2 mg/kg/day |
66 |
Develop. |
Final |
11/2010 |
7440-42-8 |
|
BROMODICHLOROMETHANE |
Oral |
Acute |
0.07 mg/kg/day |
100 |
Develop. |
Final |
03/2020 |
75-27-4 |
Oral |
Chr. |
0.008 mg/kg/day |
100 |
Hepatic |
Final |
03/2020 |
75-27-4 |
|
BROMOFORM |
Oral |
Acute |
0.7 mg/kg/day |
100 |
Hepatic |
Final |
08/2005 |
75-25-2 |
Oral |
Int. |
0.2 mg/kg/day |
100 |
Hepatic |
Final |
08/2005 |
75-25-2 |
Oral |
Chr. |
0.02 mg/kg/day |
3000 |
Hepatic |
Final |
08/2005 |
75-25-2 |
|
BROMOMETHANE |
Inh. |
Int. |
0.02 ppm |
90 |
Neurol. |
Final |
03/2020 |
74-83-9 |
Inh. |
Chr. |
0.001 ppm |
90 |
Resp. |
Final |
03/2020 |
74-83-9 |
|
2-CHLOROPHENOL |
Oral |
Int. |
0.08 mg/kg/day |
100 |
Reprod. |
Final |
06/2022 |
95-57-8 |
|
4-CHLOROPHENOL |
Oral |
Int. |
0.9 mg/kg/day |
100 |
Reprod. |
Final |
06/2022 |
106-48-9 |
|
CADMIUM |
Inh. |
Acute |
0.00003 mg/m3 |
300 |
Resp. |
Final |
09/2012 |
7440-43-9 |
Inh. |
Chr. |
0.00001 mg/m3 |
9 |
Renal |
Final |
09/2012 |
7440-43-9 |
Oral |
Int. |
0.0005 mg/kg/day |
100 |
Musculo. |
Final |
09/2012 |
7440-43-9 |
Oral |
Chr. |
0.0001 mg/kg/day |
3 |
Renal |
Final |
09/2012 |
7440-43-9 |
|
CARBON DISULFIDE |
Inh. |
Chr. |
0.3 ppm |
30 |
Neurol. |
Final |
08/1996 |
75-15-0 |
Oral |
Acute |
0.01 mg/kg/day |
300 |
Hepatic |
Final |
08/1996 |
75-15-0 |
|
CARBON TETRACHLORIDE |
Inh. |
Int. |
0.03 ppm |
30 |
Hepatic |
Final |
08/2005 |
56-23-5 |
Inh. |
Chr. |
0.03 ppm |
30 |
Hepatic |
Final |
08/2005 |
56-23-5 |
Oral |
Acute |
0.02 mg/kg/day |
300 |
Hepatic |
Final |
08/2005 |
56-23-5 |
Oral |
Int. |
0.007 mg/kg/day |
100 |
Hepatic |
Final |
08/2005 |
56-23-5 |
|
CESIUM |
Rad. |
Acute |
4 mSv |
3 |
Develop. |
Final |
04/2004 |
7440-46-2 |
Rad. |
Chr. |
1 mSv/yr |
3 |
Other |
Final |
04/2004 |
7440-46-2 |
|
CHLORDANE |
Inh. |
Int. |
0.0002 mg/m3 |
100 |
Hepatic |
Final |
02/2018 |
12789-03-6 |
Inh. |
Chr. |
0.00002 mg/m3 |
1000 |
Hepatic |
Final |
02/2018 |
12789-03-6 |
Oral |
Acute |
0.001 mg/kg/day |
1000 |
Develop. |
Final |
02/2018 |
12789-03-6 |
Oral |
Int. |
0.0006 mg/kg/day |
100 |
Hepatic |
Final |
02/2018 |
12789-03-6 |
Oral |
Chr. |
0.0006 mg/kg/day |
100 |
Hepatic |
Final |
02/2018 |
12789-03-6 |
|
CHLORDECONE |
Oral |
Acute |
0.01 mg/kg/day |
100 |
Neurol. |
Final |
10/2020 |
143-50-0 |
Oral |
Int. |
3 ug/kg/day |
100 |
Neurol.,Reprod. |
Final |
10/2020 |
143-50-0 |
Oral |
Chr. |
0.9 ug/kg/day |
100 |
Renal |
Final |
10/2020 |
143-50-0 |
|
CHLORFENVINPHOS |
Oral |
Acute |
0.002 mg/kg/day |
1000 |
Neurol. |
Final |
09/1997 |
470-90-6 |
Oral |
Int. |
0.002 mg/kg/day |
1000 |
Immuno. |
Final |
09/1997 |
470-90-6 |
Oral |
Chr. |
0.0007 mg/kg/day |
1000 |
Neurol. |
Final |
09/1997 |
470-90-6 |
|
CHLORINE |
Inh. |
Acute |
0.06 ppm |
3 |
Resp. |
Final |
11/2010 |
7782-50-5 |
Inh. |
Int. |
0.002 ppm |
90 |
Resp. |
Final |
11/2010 |
7782-50-5 |
Inh. |
Chr. |
0.00005 ppm |
30 |
Resp. |
Final |
11/2010 |
7782-50-5 |
|
CHLORINE DIOXIDE |
Inh. |
Int. |
0.001 ppm |
300 |
Resp. |
Final |
09/2004 |
10049-04-4 |
|
CHLORITE |
Oral |
Int. |
0.1 mg/kg/day |
30 |
Develop. |
Final |
09/2004 |
7758-19-2 |
|
CHLOROBENZENE |
Oral |
Int. |
0.07 mg/kg/day |
100 |
Hepatic |
Final |
10/2020 |
108-90-7 |
|
CHLOROETHANE |
Inh. |
Acute |
15 ppm |
100 |
Develop. |
Final |
12/1998 |
75-00-3 |
|
CHLOROFORM |
Inh. |
Acute |
0.1 ppm |
30 |
Hepatic |
Final |
09/1997 |
67-66-3 |
Inh. |
Int. |
0.05 ppm |
300 |
Hepatic |
Final |
09/1997 |
67-66-3 |
Inh. |
Chr. |
0.02 ppm |
100 |
Hepatic |
Final |
09/1997 |
67-66-3 |
Oral |
Acute |
0.3 mg/kg/day |
100 |
Hepatic |
Final |
09/1997 |
67-66-3 |
Oral |
Int. |
0.1 mg/kg/day |
100 |
Hepatic |
Final |
09/1997 |
67-66-3 |
Oral |
Chr. |
0.01 mg/kg/day |
1000 |
Hepatic |
Final |
09/1997 |
67-66-3 |
|
CHLOROMETHANE |
Inh. |
Acute |
0.5 ppm |
90 |
Neurol. |
Draft |
01/2022 |
74-87-3 |
Inh. |
Chr. |
0.03 ppm |
300 |
Neurol. |
Draft |
01/2022 |
74-87-3 |
|
CHLORPYRIFOS |
Oral |
Acute |
0.003 mg/kg/day |
10 |
Neurol. |
Final |
09/1997 |
2921-88-2 |
Oral |
Int. |
0.003 mg/kg/day |
10 |
Neurol. |
Final |
09/1997 |
2921-88-2 |
Oral |
Chr. |
0.001 mg/kg/day |
100 |
Neurol. |
Final |
09/1997 |
2921-88-2 |
|
CHROMIUM(III) INSOL. PARTICULATES |
Inh. |
Int. |
0.005 mg/m3 |
90 |
Resp. |
Final |
09/2012 |
16065-83-1 |
|
CHROMIUM(III) SOLUBLE PARTICULATES |
Inh. |
Int. |
0.0001 mg/m3 |
300 |
Resp. |
Final |
09/2012 |
16065-83-1 |
|
CHROMIUM(VI) |
Oral |
Int. |
0.005 mg/kg/day |
100 |
Hemato. |
Final |
09/2012 |
18540-29-9 |
Oral |
Chr |
0.0009 mg/kg/day |
100 |
Gastro. |
Final |
09/2012 |
18540-29-9 |
|
CHROMIUM(VI), AEROSOL MISTS |
Inh. |
Int. |
0.000005 mg/m3 |
100 |
Resp. |
Final |
09/2012 |
18540-29-9 |
Inh. |
Chr. |
0.000005 mg/m3 |
100 |
Resp. |
Final |
09/2012 |
18540-29-9 |
|
CHROMIUM(VI), PARTICULATES |
Inh. |
Int. |
0.0003 mg/m3 |
30 |
Resp. |
Final |
09/2012 |
18540-29-9 |
|
COBALT |
Inh. |
Chr. |
0.0001 mg/m3 |
10 |
Resp. |
Final |
04/2004 |
7440-48-4 |
Oral |
Int. |
0.01 mg/kg/day |
100 |
Hemato. |
Final |
04/2004 |
7440-48-4 |
Rad. |
Acute |
4 mSv |
3 |
Develop. |
Final |
04/2004 |
7440-48-4 |
Rad. |
Chr. |
1 mSv/yr |
3 |
Other |
Final |
04/2004 |
7440-48-4 |
|
COPPER |
Oral |
Acute |
0.02 mg/kg/day |
3 |
Gastro. |
Draft |
04/2022 |
7440-50-8 |
Oral |
Int. |
0.02 mg/kg/day |
3 |
Gastro. |
Draft |
04/2022 |
7440-50-8 |
|
CRESOLS |
Oral |
Int. |
0.1 mg/kg/day |
100 |
Resp. |
Final |
09/2008 |
1319-77-3 |
Oral |
Chr. |
0.1 mg/kg/day |
1000 |
Resp. |
Final |
09/2008 |
1319-77-3 |
|
CYANIDE, SODIUM |
Oral |
Int. |
0.05 mg/kg/day |
100 |
Repro. |
Final |
07/2006 |
143-33-9 |
|
CYHALOTHRIN |
Oral |
Acute |
0.01 mg/kg/day |
100 |
Gastro. |
Final |
09/2003 |
68085-85-8 |
Oral |
Int. |
0.01 mg/kg/day |
100 |
Gastro. |
Final |
09/2003 |
68085-85-8 |
|
CYPERMETHRIN |
Oral |
Acute |
0.02 mg/kg/day |
1000 |
Neurol. |
Final |
09/2003 |
52315-07-8 |
|
DIBROMOCHLOROMETHANE |
Oral |
Acute |
0.1 mg/kg/day |
300 |
Hepatic |
Final |
08/2005 |
124-48-1 |
Oral |
Chr. |
0.09 mg/kg/day |
300 |
Hepatic |
Final |
08/2005 |
124-48-1 |
|
1,1-DICHLOROETHENE |
Inh. |
Int. |
1 ppb |
30 |
Resp. |
Final |
04/2022 |
75-35-4 |
Inh. |
Chr. |
1 ppb |
30 |
Resp. |
Final |
04/2022 |
75-35-4 |
Oral |
Chr. |
0.05 mg/kg/day |
100 |
Hepatic |
Final |
04/2022 |
75-35-4 |
|
1,1-DIMETHYLHYDRAZINE |
Inh. |
Int. |
0.0002 ppm |
300 |
Hepatic |
Final |
09/1997 |
57-14-7 |
|
1,2-DIBROMO-3-CHLOROPROPANE |
Inh. |
Int. |
0.0002 ppm |
100 |
Repro. |
Final |
04/2018 |
96-12-8 |
Oral |
Int. |
0.002 mg/kg/day |
1000 |
Repro. |
Final |
04/2018 |
96-12-8 |
|
1,2-DICHLOROBENZENE |
Oral |
Acute |
0.7 mg/kg/day |
100 |
Hepatic |
Final |
08/2006 |
95-50-1 |
Oral |
Int. |
0.6 mg/kg/day |
100 |
Hepatic |
Final |
08/2006 |
95-50-1 |
Oral |
Chr. |
0.3 mg/kg/day |
100 |
Renal |
Final |
08/2006 |
95-50-1 |
|
1,2-DICHLOROETHANE |
Inh. |
Acute |
0.3 ppm |
30 |
Resp. |
Draft |
01/2022 |
107-06-2 |
Oral |
Int. |
0.2 mg/kg/day |
300 |
Renal |
Draft |
01/2022 |
107-06-2 |
|
1,2-DICHLOROETHENE, CIS- |
Oral |
Acute |
1 mg/kg/day |
100 |
Hemato. |
Final |
08/1996 |
156-59-2 |
Oral |
Int. |
0.3 mg/kg/day |
100 |
Hemato. |
Final |
08/1996 |
156-59-2 |
|
1,2-DICHLOROETHENE, TRANS- |
Inh. |
Acute |
0.2 ppm |
1000 |
Hepatic |
Final |
08/1996 |
156-60-5 |
Inh. |
Int. |
0.2 ppm |
1000 |
Hepatic |
Final |
08/1996 |
156-60-5 |
Oral |
Int. |
0.2 mg/kg/day |
100 |
Hepatic |
Final |
08/1996 |
156-60-5 |
|
1,2-DICHLOROPROPANE |
Inh. |
Acute |
0.02 ppm |
90 |
Resp. |
Final |
11/2021 |
78-87-5 |
Inh. |
Int. |
2 ppb |
30 |
Resp. |
Final |
11/2021 |
78-87-5 |
Oral |
Acute |
0.3 mg/kg/day |
100 |
Hemato. |
Final |
11/2021 |
78-87-5 |
Oral |
Int. |
0.07 mg/kg/day |
1000 |
Hemato. |
Final |
11/2021 |
78-87-5 |
|
1,2-DIMETHYLHYDRAZINE |
Oral |
Int. |
0.0008 mg/kg/day |
1000 |
Hepatic |
Final |
09/1997 |
540-73-8 |
|
1,2-DIPHENYLHYDRAZINE |
Oral |
Int. |
0.05 mg/kg/day |
100 |
Hepatic |
Final |
10/2020 |
122-66-7 |
|
1,3-DICHLOROBENZENE |
Oral |
Acute |
0.4 mg/kg/day |
100 |
Hepatic |
Final |
08/2006 |
541-73-1 |
Oral |
Int. |
0.02 mg/kg/day |
100 |
Endocr. |
Final |
08/2006 |
541-73-1 |
|
1,3-DICHLOROPROPENE |
Inh. |
Int. |
0.008 ppm |
30 |
Resp. |
Final |
09/2008 |
542-75-6 |
Inh. |
Chr. |
0.007 ppm |
30 |
Resp. |
Final |
09/2008 |
542-75-6 |
Oral |
Int. |
0.04 mg/kg/day |
100 |
Gastro. |
Final |
09/2008 |
542-75-6 |
Oral |
Chr. |
0.03 mg/kg/day |
100 |
Gastro. |
Final |
09/2008 |
542-75-6 |
|
1,3-DINITROBENZENE |
Oral |
Acute |
0.08 mg/kg/day |
100 |
Repro. |
Final |
06/1995 |
99-65-0 |
Oral |
Int. |
0.0005 mg/kg/day |
1000 |
Hemato. |
Final |
06/1995 |
99-65-0 |
|
1,4-DICHLOROBENZENE |
Inh. |
Acute |
2 ppm |
10 |
Resp. |
Final |
08/2006 |
106-46-7 |
Inh. |
Int. |
0.2 ppm |
100 |
Hepatic |
Final |
08/2006 |
106-46-7 |
Inh. |
Chr. |
0.01 ppm |
30 |
Resp. |
Final |
08/2006 |
106-46-7 |
Oral |
Int. |
0.07 mg/kg/day |
100 |
Hepatic |
Final |
08/2006 |
106-46-7 |
Oral |
Chr. |
0.07 mg/kg/day |
100 |
Hepatic |
Final |
08/2006 |
106-46-7 |
|
1,4-DIOXANE |
Inh. |
Acute |
2 ppm |
10 |
Ocular |
Final |
04/2012 |
123-91-1 |
Inh. |
Int. |
0.2 ppm |
30 |
Resp. |
Final |
04/2012 |
123-91-1 |
Inh. |
Chr. |
0.03 ppm |
300 |
Resp. |
Final |
04/2012 |
123-91-1 |
Oral |
Acute |
5 mg/kg/day |
100 |
Develop. |
Final |
04/2012 |
123-91-1 |
Oral |
Int. |
0.5 mg/kg/day |
100 |
Hepatic |
Final |
04/2012 |
123-91-1 |
Oral |
Chr. |
0.1 mg/kg/day |
100 |
Hepatic |
Final |
04/2012 |
123-91-1 |
|
2,3-DICHLOROPROPENE |
Inh. |
Acute |
0.002 ppm |
90 |
Resp. |
Final |
09/2008 |
78-88-6 |
|
2,3-DINITROTOLUENE |
Oral |
Acute |
0.09 mg/kg/day |
3000 |
Renal |
Final |
02/2016 |
602-01-7 |
|
2,4-DICHLOROPHENOL |
Oral |
Int. |
0.02 mg/kg/day |
100 |
Immuno. |
Final |
06/2022 |
120-83-2 |
|
2,4-DICHLOROPHENOXYACETIC ACID (2,4-D) |
Oral |
Int. |
0.2 mg/kg/day |
100 |
Renal |
Final |
07/2020 |
94-75-7 |
Oral |
Chronic |
0.2 mg/kg/day |
100 |
Renal |
Final |
07/2020 |
94-75-7 |
|
2,4-DINITROPHENOL |
Oral |
Int. |
0.07 ug/kg/day |
1000 |
Body Wt. |
Final |
08/2021 |
51-28-5 |
|
2,4-DINITROTOLUENE |
Oral |
Acute |
0.05 mg/kg/day |
100 |
Neurol. |
Final |
02/2016 |
121-14-2 |
Oral |
Int. |
0.007 mg/kg/day |
100 |
Hemato. |
Final |
02/2016 |
121-14-2 |
Oral |
Chr. |
0.001 mg/kg/day |
100 |
Hemato. |
Final |
02/2016 |
121-14-2 |
|
2,5-DINITROTOLUENE |
Oral |
Acute |
0.007 mg/kg/day |
300 |
Hemato. |
Final |
02/2016 |
619-15-8 |
|
2,6-DINITROTOLUENE |
Oral |
Acute |
0.09 mg/kg/day |
100 |
Hemato. |
Final |
02/2016 |
606-20-2 |
Oral |
Int. |
0.004 mg/kg/day |
1000 |
Hemato. |
Final |
02/2016 |
606-20-2 |
|
3,4-DINITROTOLUENE |
Oral |
Acute |
0.03 mg/kg/day |
300 |
Hemato. |
Final |
02/2016 |
610-39-9 |
|
3,5-DINITROTOLUENE |
Oral |
Acute |
0.03 mg/kg/day |
300 |
Repro. |
Final |
02/2016 |
618-85-9 |
|
4,6-DINITRO-O-CRESOL |
Oral |
Acute |
0.004 mg/kg/day |
100 |
Neurol. |
Final |
01/2018 |
534-52-1 |
Oral |
Int. |
0.004 mg/kg/day |
100 |
Neurol. |
Final |
01/2018 |
534-52-1 |
|
DDD, P,P'- |
Oral |
Acute |
0.5 ug/kg/day |
1000 |
Develop. |
Final |
04/2022 |
72-54-8 |
Oral |
Int. |
0.5 ug/kg/day |
100 |
Hepatic |
Final |
04/2022 |
72-54-8 |
Oral |
Chr. |
0.5 ug/kg/day |
100 |
Hepatic |
Final |
04/2022 |
72-54-8 |
|
DDE, P,P'- |
Oral |
Acute |
0.5 ug/kg/day |
1000 |
Develop. |
Final |
04/2022 |
72-55-9 |
Oral |
Int. |
0.5 ug/kg/day |
100 |
Hepatic |
Final |
04/2022 |
72-55-9 |
Oral |
Chr. |
0.5 ug/kg/day |
100 |
Hepatic |
Final |
04/2022 |
72-55-9 |
|
DDT, P,P'- |
Oral |
Acute |
0.5 ug/kg/day |
1000 |
Develop. |
Final |
04/2022 |
50-29-3 |
Oral |
Int. |
0.5 ug/kg/day |
100 |
Hepatic |
Final |
04/2022 |
50-29-3 |
Oral |
Chr. |
0.5 ug/kg/day |
100 |
Hepatic |
Final |
04/2022 |
50-29-3 |
|
DEET (N,N-DIETHYL-META-TOLUAMIDE) |
Oral |
Int. |
1 mg/kg/day |
100 |
Develop. |
Final |
08/2017 |
134-62-3 |
|
DI(2-ETHYLHEXYL)PHTHALATE (DEHP) |
Inh. |
Int. |
0.2 ppb |
300 |
Develop. |
Final |
01/2022 |
117-81-7 |
Oral |
Acute |
3 ug/kg/day |
300 |
Develop. |
Final |
01/2022 |
117-81-7 |
Oral |
Int. |
0.1 ug/kg/day |
300 |
Develop. |
Final |
01/2022 |
117-81-7 |
|
DIAZINON |
Inh. |
Int. |
0.01 mg/m3 |
30 |
Neurol. |
Final |
09/2008 |
333-41-5 |
Oral |
Acute |
0.006 mg/kg/day |
100 |
Neurol. |
Final |
09/2008 |
333-41-5 |
Oral |
Int. |
0.002 mg/kg/day |
100 |
Neurol. |
Final |
09/2008 |
333-41-5 |
Oral |
Chr. |
0.0007 mg/kg/day |
100 |
Neurol. |
Final |
09/2008 |
333-41-5 |
|
DICHLORVOS |
Inh. |
Acute |
0.002 ppm |
100 |
Neurol. |
Final |
09/1997 |
62-73-7 |
Inh. |
Int. |
0.0003 ppm |
100 |
Neurol. |
Final |
09/1997 |
62-73-7 |
Inh. |
Chr. |
0.00006 ppm |
100 |
Neurol. |
Final |
09/1997 |
62-73-7 |
Oral |
Acute |
0.004 mg/kg/day |
1000 |
Neurol. |
Final |
09/1997 |
62-73-7 |
Oral |
Int. |
0.003 mg/kg/day |
10 |
Neurol. |
Final |
09/1997 |
62-73-7 |
Oral |
Chr. |
0.0005 mg/kg/day |
100 |
Neurol. |
Final |
09/1997 |
62-73-7 |
|
DIELDRIN |
Oral |
Int. |
0.1 ug/kg/day |
100 |
Neurol. |
Final |
06/2022 |
60-57-1 |
Oral |
Chr. |
0.05 ug/kg/day |
100 |
Hepatic |
Final |
06/2022 |
60-57-1 |
|
DIETHYL PHTHALATE |
Oral |
Acute |
7 mg/kg/day |
300 |
Repro. |
Final |
06/1995 |
84-66-2 |
Oral |
Int. |
6 mg/kg/day |
300 |
Hepatic |
Final |
06/1995 |
84-66-2 |
|
DIISOPROPYL METHYLPHOSPHONATE (DIMP) |
Oral |
Int. |
0.8 mg/kg/day |
100 |
Hemato. |
Final |
08/1998 |
1445-75-6 |
Oral |
Chr. |
0.6 mg/kg/day |
100 |
Hemato. |
Final |
08/1998 |
1445-75-6 |
|
DIMETHYLARSINIC ACID (DMA) |
Oral |
Chr. |
0.02 mg/kg/day |
100 |
Renal |
Final |
08/2007 |
75-60-5 |
|
DI-N-BUTYL PHTHALATE |
Oral |
Acute |
0.5 mg/kg/day |
100 |
Develop. |
Final |
09/2001 |
84-74-2 |
|
DI-N-OCTYL PHTHALATE |
Oral |
Acute |
3 mg/kg/day |
300 |
Hepatic |
Final |
09/1997 |
117-84-0 |
Oral |
Int. |
0.4 mg/kg/day |
100 |
Hepatic |
Final |
09/1997 |
117-84-0 |
|
DISULFOTON |
Inh. |
Acute |
0.6 ug/m3 |
30 |
Neurol. |
Final |
08/2022 |
298-04-4 |
Inh. |
Int. |
0.6 ug/m3 |
30 |
Neurol. |
Final |
08/2022 |
298-04-4 |
Oral |
Acute |
0.3 ug/kg/day |
100 |
Neurol. |
Final |
08/2022 |
298-04-4 |
Oral |
Int. |
0.09 ug/kg/day |
100 |
Neurol., Develop. |
Final |
08/2022 |
298-04-4 |
Oral |
Chr. |
0.06 ug/kg/day |
1000 |
Neurol. |
Final |
08/2022 |
298-04-4 |
|
ENDOSULFAN |
Oral |
Acute |
0.007 mg/kg/day |
100 |
Neurol. |
Final |
08/2015 |
115-29-7 |
Oral |
Int. |
0.005 mg/kg/day |
100 |
Immuno. |
Final |
08/2015 |
115-29-7 |
Oral |
Chr. |
0.005 mg/kg/day |
100 |
Immuno. |
Final |
08/2015 |
115-29-7 |
|
ENDRIN |
Oral |
Acute |
0.6 ug/kg/day |
100 |
Neurol. |
Final |
03/2021 |
72-20-8 |
Oral |
Int. |
0.6 ug/kg/day |
100 |
Neurol. |
Final |
03/2021 |
72-20-8 |
Oral |
Chr. |
0.3 ug/kg/day |
100 |
Neurol.,Hepatic |
Final |
03/2021 |
72-20-8 |
|
ETHION |
Oral |
Acute |
0.002 mg/kg/day |
30 |
Neurol. |
Final |
09/2000 |
563-12-2 |
Oral |
Int. |
0.002 mg/kg/day |
30 |
Neurol. |
Final |
09/2000 |
563-12-2 |
Oral |
Chr. |
0.0004 mg/kg/day |
150 |
Neurol. |
Final |
09/2000 |
563-12-2 |
|
ETHYLBENZENE |
Inh. |
Acute |
5 ppm |
30 |
Neurol. |
Final |
11/2010 |
100-41-4 |
Inh. |
Int. |
2 ppm |
30 |
Neurol. |
Final |
11/2010 |
100-41-4 |
Inh. |
Chr. |
0.06 ppm |
300 |
Renal |
Final |
11/2010 |
100-41-4 |
Oral |
Int. |
0.4 mg/kg/day |
30 |
Hepatic |
Final |
11/2010 |
100-41-4 |
|
ETHYLENE GLYCOL |
Inh. |
Acute |
2 mg/m3 |
10 |
Renal |
Final |
11/2010 |
107-21-1 |
Oral |
Acute |
0.8 mg/kg/day |
100 |
Develop. |
Final |
11/2010 |
107-21-1 |
Oral |
Int. |
0.8 mg/kg/day |
100 |
Develop. |
Final |
11/2010 |
107-21-1 |
|
ETHYLENE OXIDE |
Inh. |
Acute |
0.4 ppm |
30 |
Develop. |
Final |
08/2022 |
75-21-8 |
Inh. |
Int. |
0.07 ppm |
30 |
Develop. |
Final |
08/2022 |
75-21-8 |
|
FLUORANTHENE |
Oral |
Int. |
0.4 mg/kg/day |
300 |
Hepatic |
Final |
08/1995 |
206-44-0 |
|
FLUORENE |
Oral |
Int. |
0.4 mg/kg/day |
300 |
Hepatic |
Final |
08/1995 |
86-73-7 |
|
FLUORIDE, SODIUM |
Oral |
Chr. |
0.05 mg/kg/day |
3 |
Musculo. |
Final |
09/2003 |
7681-49-4 |
|
FLUORINE |
Inh. |
Acute |
0.01 ppm |
10 |
Resp. |
Final |
09/2003 |
7782-41-4 |
|
FORMALDEHYDE |
Inh. |
Acute |
0.04 ppm |
9 |
Resp. |
Final |
07/1999 |
50-00-0 |
Inh. |
Int. |
0.03 ppm |
30 |
Resp. |
Final |
07/1999 |
50-00-0 |
Inh. |
Chr. |
0.008 ppm |
30 |
Resp. |
Final |
07/1999 |
50-00-0 |
Oral |
Int. |
0.3 mg/kg/day |
100 |
Gastro. |
Final |
07/1999 |
50-00-0 |
Oral |
Chr. |
0.2 mg/kg/day |
100 |
Gastro. |
Final |
07/1999 |
50-00-0 |
|
FUEL OIL NO.2 |
Inh. |
Acute |
0.02 mg/m3 |
1000 |
Neurol. |
Final |
06/1995 |
68476-30-2 |
|
GLUTARALDEHYDE |
Inh. |
Acute |
0.001 ppm |
3 |
Resp. |
Final |
07/2017 |
111-30-8 |
Inh. |
Int. |
0.00003 ppm |
3 |
Resp. |
Final |
07/2017 |
111-30-8 |
Oral |
Chr. |
0.1 mg/kg/day |
30 |
Gastro. |
Final |
07/2017 |
111-30-8 |
|
GLYPHOSATE TECHNICAL |
Oral |
Acute |
1 mg/kg/day |
100 |
Gastro. |
Final |
08/2020 |
1071-83-6 |
Oral |
Int. |
1 mg/kg/day |
100 |
Gastro. |
Final |
08/2020 |
1071-83-6 |
Oral |
Chr. |
1 mg/kg/day |
100 |
Gastro. |
Final |
08/2020 |
1071-83-6 |
|
GUTHION (AZINPHOS-METHYL) |
Inh. |
Acute |
0.02 mg/m3 |
30 |
Neurol. |
Final |
09/2008 |
86-50-0 |
Inh. |
Int. |
0.01 mg/m3 |
30 |
Neurol. |
Final |
09/2008 |
86-50-0 |
Inh. |
Chr. |
0.01 mg/m3 |
30 |
Neurol. |
Final |
09/2008 |
86-50-0 |
Oral |
Acute |
0.01 mg/kg/day |
100 |
Neurol. |
Final |
09/2008 |
86-50-0 |
Oral |
Int. |
0.003 mg/kg/day |
100 |
Neurol. |
Final |
09/2008 |
86-50-0 |
Oral |
Chr. |
0.003 mg/kg/day |
100 |
Neurol. |
Final |
09/2008 |
86-50-0 |
|
1,2,3,6,7,8-HEXACHLORODIBENZOFURAN |
Oral |
Int. |
5 ng/kg/day |
100 |
Hepatic, Endocrine |
Draft |
01/2022 |
57117-44-9 |
|
2-HEXANONE |
Oral |
Chr. |
0.05 mg/kg/day |
3000 |
Neurol. |
Final |
02/2020 |
591-78-6 |
|
HEPTACHLOR |
Oral |
Acute |
0.0006 mg/kg/day |
3000 |
Repro. |
Final |
08/2007 |
76-44-8 |
Oral |
Int. |
0.0001 mg/kg/day |
300 |
Immuno. |
Final |
08/2007 |
76-44-8 |
|
HEXACHLOROBENZENE |
Oral |
Acute |
0.008 mg/kg/day |
300 |
Develop. |
Final |
08/2015 |
118-74-1 |
Oral |
Int. |
0.0001 mg/kg/day |
90 |
Repro. |
Final |
08/2015 |
118-74-1 |
Oral |
Chr. |
0.00007 mg/kg/day |
300 |
Hepatic |
Final |
08/2015 |
118-74-1 |
|
HEXACHLOROBUTADIENE |
Oral |
Acute |
6 ug/kg/day |
1000 |
Renal |
Final |
03/2021 |
87-68-3 |
Oral |
Int. |
2 ug/kg/day |
100 |
Renal |
Final |
03/2021 |
87-68-3 |
|
HEXACHLOROCYCLOHEXANE, ALPHA- |
Oral |
Chr. |
0.008 mg/kg/day |
100 |
Hepatic |
Final |
08/2005 |
319-84-6 |
|
HEXACHLOROCYCLOHEXANE, BETA- |
Oral |
Acute |
0.05 mg/kg/day |
100 |
Neurol. |
Final |
08/2005 |
319-85-7 |
Oral |
Int. |
0.0006 mg/kg/day |
300 |
Hepatic |
Final |
08/2005 |
319-85-7 |
|
HEXACHLOROCYCLOHEXANE, GAMMA- |
Oral |
Acute |
0.003 mg/kg/day |
300 |
Reprod. |
Final |
08/2005 |
58-89-9 |
Oral |
Int. |
0.00001 mg/kg/day |
1000 |
Immuno. |
Final |
08/2005 |
58-89-9 |
|
HEXACHLOROCYCLOPENTADIENE |
Inh. |
Int. |
0.01 ppm |
30 |
Resp. |
Final |
07/1999 |
77-47-4 |
Inh. |
Chr. |
0.0002 ppm |
90 |
Resp. |
Final |
07/1999 |
77-47-4 |
Oral |
Int. |
0.1 mg/kg/day |
100 |
Renal |
Final |
07/1999 |
77-47-4 |
|
HEXACHLOROETHANE |
Inh. |
Acute |
6 ppm |
30 |
Neurol. |
Final |
09/1997 |
67-72-1 |
Inh. |
Int. |
6 ppm |
30 |
Neurol. |
Final |
09/1997 |
67-72-1 |
Oral |
Acute |
1 mg/kg/day |
100 |
Hepatic |
Final |
09/1997 |
67-72-1 |
Oral |
Int. |
0.01 mg/kg/day |
100 |
Hepatic |
Final |
09/1997 |
67-72-1 |
|
HEXAMETHYLENE DIISOCYANATE |
Inh. |
Int. |
0.00003 ppm |
30 |
Resp. |
Final |
08/1998 |
822-06-0 |
Inh. |
Chr. |
0.00001 ppm |
90 |
Resp. |
Final |
08/1998 |
822-06-0 |
|
HEXANE, N- |
Inh. |
Chr. |
0.6 ppm |
100 |
Neurol. |
Final |
07/1999 |
110-54-3 |
|
HMX (CYCLOTETRAMETHYLENE TETRANITRAMINE) |
Oral |
Acute |
0.1 mg/kg/day |
1000 |
Neurol. |
Final |
09/1997 |
2691-41-0 |
Oral |
Int. |
0.05 mg/kg/day |
1000 |
Hepatic |
Final |
09/1997 |
2691-41-0 |
|
HYDRAZINE |
Inh. |
Int. |
0.004 ppm |
300 |
Hepatic |
Final |
09/1997 |
302-01-2 |
|
HYDROGEN FLUORIDE |
Inh. |
Acute |
0.02 ppm |
30 |
Resp. |
Final |
09/2003 |
7664-39-3 |
|
HYDROGEN SULFIDE |
Inh. |
Acute |
0.07 ppm |
27 |
Resp. |
Final |
11/2016 |
7783-06-4 |
Inh. |
Int. |
0.02 ppm |
30 |
Resp. |
Final |
11/2016 |
7783-06-4 |
|
IODIDE |
Oral |
Acute |
0.01 mg/kg/day |
1 |
Endocr. |
Final |
04/2004 |
7553-56-2 |
Oral |
Chr. |
0.01 mg/kg/day |
1 |
Endocr. |
Final |
04/2004 |
7553-56-2 |
|
IONIZING RADIATION, N.O.S. |
Rad. |
Acute |
4 mSv |
3 |
Neurol. |
Final |
09/1999 |
HZ1800-45-T |
Rad. |
Chr. |
1 mSv/yr |
3 |
Other |
Final |
09/1999 |
HZ1800-45-T |
|
ISOPHORONE |
Oral |
Int. |
3 mg/kg/day |
100 |
Other |
Final |
07/2018 |
78-59-1 |
Oral |
Chr. |
0.2 mg/kg/day |
1000 |
Hepatic |
Final |
07/2018 |
78-59-1 |
|
JP-4 |
Inh. |
Int. |
9 mg/m3 |
300 |
Hepatic |
Final |
06/1995 |
50815-00-4 |
|
JP-5 |
Inh. |
Int. |
2 mg/m<sup>3</sup> |
90 |
Hepatic |
Final |
03/2017 |
8008-20-6 |
|
JP-7 |
Inh. |
Chr. |
0.3 mg/m3 |
300 |
Hepatic |
Final |
06/1995 |
HZ0600-22-T |
|
JP-8 |
Inh. |
Int. |
3 mg/m<sup>3</sup> |
30 |
Neurol. |
Final |
03/2017 |
8008-20-6 |
Oral |
Acute |
3 mg/kg/day |
100 |
Immuno. |
Final |
03/2017 |
8008-20-6 |
Oral |
Int. |
0.3 mg/kg/day |
1000 |
Develop. |
Final |
03/2017 |
8008-20-6 |
|
KEROSENE |
Inh. |
Int. |
0.01 mg/m3 |
1000 |
Hepatic |
Final |
06/1995 |
8008-20-6 |
|
1-METHYLNAPHTHALENE |
Oral |
Chr. |
0.07 mg/kg/day |
1000 |
Resp. |
Final |
08/2005 |
90-12-0 |
|
2-METHYLNAPHTHALENE |
Oral |
Chr. |
0.04 mg/kg/day |
100 |
Resp. |
Final |
08/2005 |
91-57-6 |
|
4,4'-METHYLENEBIS(2-CHLOROANILINE) (MBOCA) |
Oral |
Chr. |
0.003 mg/kg/day |
3000 |
Hepatic |
Final |
10/2017 |
101-14-4 |
|
4,4'-METHYLENEDIANILINE |
Oral |
Acute |
0.2 mg/kg/day |
150 |
Hepatic |
Final |
08/1998 |
101-77-9 |
Oral |
Int. |
0.08 mg/kg/day |
100 |
Hepatic |
Final |
08/1998 |
101-77-9 |
|
MALATHION |
Inh. |
Acute |
0.2 mg/m3 |
100 |
Neurol. |
Final |
09/2003 |
121-75-5 |
Inh. |
Int. |
0.02 mg/m3 |
1000 |
Resp. |
Final |
09/2003 |
121-75-5 |
Oral |
Int. |
0.02 mg/kg/day |
10 |
Neurol. |
Final |
09/2003 |
121-75-5 |
Oral |
Chr. |
0.02 mg/kg/day |
100 |
Neurol. |
Final |
09/2003 |
121-75-5 |
|
MANGANESE, RESPIRABLE |
Inh. |
Chr. |
0.3 ug/m3 |
100 |
Neurol. |
Final |
09/2012 |
7439-96-5 |
|
MERCURY |
Inh. |
Chr. |
0.3 ug/m3 |
10 |
Neurol. |
Draft |
04/2022 |
7439-97-6 |
|
MERCURY, INORGANIC SALTS (MERCURIC CHLORIDE, ETC.) |
Oral |
Acute |
2 ug/kg/day |
100 |
Renal |
Draft |
04/2022 |
7487-94-7 |
Oral |
Int. |
0.01 ug/kg/day |
1000 |
Renal |
Draft |
04/2022 |
7487-94-7 |
|
METHOXYCHLOR |
Oral |
Int. |
0.005 mg/kg/day |
1000 |
Repro. |
Final |
09/2002 |
72-43-5 |
|
METHYL PARATHION |
Oral |
Int. |
0.0007 mg/kg/day |
300 |
Neurol. |
Final |
09/2001 |
298-00-0 |
Oral |
Chr. |
0.0003 mg/kg/day |
100 |
Hemato. |
Final |
09/2001 |
298-00-0 |
|
METHYL tert-BUTYL ETHER (MTBE) |
Inh. |
Acute |
2 ppm |
30 |
Neurol. |
Draft |
01/2022 |
1634-04-4 |
Inh. |
Int. |
1 ppm |
30 |
Neurol.,Hepatic |
Draft |
01/2022 |
1634-04-4 |
Inh. |
Chr. |
1 ppm |
30 |
Renal |
Draft |
01/2022 |
1634-04-4 |
Oral |
Int. |
0.6 mg/kg/day |
100 |
Neurol. |
Draft |
01/2022 |
1634-04-4 |
|
METHYLENE CHLORIDE |
Inh. |
Acute |
0.6 ppm |
100 |
Neurol. |
Final |
09/2000 |
75-09-2 |
Inh. |
Int. |
0.3 ppm |
90 |
Hepatic |
Final |
09/2000 |
75-09-2 |
Inh. |
Chr. |
0.3 ppm |
30 |
Hepatic |
Final |
09/2000 |
75-09-2 |
Oral |
Acute |
0.2 mg/kg/day |
100 |
Neurol. |
Final |
09/2000 |
75-09-2 |
Oral |
Chr. |
0.06 mg/kg/day |
100 |
Hepatic |
Final |
09/2000 |
75-09-2 |
|
METHYLENEDIPHENYL DIISOCYANATE (MDI), POLYMERIC |
Inh. |
Chr. |
0.001 mg/m3 |
30 |
Resp. |
Final |
06/2018 |
9016-87-9 |
|
METHYLMERCURY |
Oral |
Chr. |
0.1 ug/kg/day |
3 |
Develop. |
Draft |
04/2022 |
22967-92-6 |
|
MIREX |
Oral |
Chr. |
0.3 ug/kg/day |
300 |
Hepatic |
Final |
10/2020 |
2385-85-5 |
|
MOLYBDENUM |
Inh. |
Chr. |
2 ug/m3 |
30 |
Resp. |
Final |
05/2020 |
1313-27-5 |
Oral |
Int. |
0.06 mg/kg/day |
300 |
Renal |
Final |
05/2020 |
7439-98-7 |
|
MONOMETHYLARSONIC ACID (MMA) |
Oral |
Int. |
0.1 mg/kg/day |
100 |
Gastro. |
Final |
08/2007 |
124-58-3 |
Oral |
Chr. |
0.01 mg/kg/day |
100 |
Renal |
Final |
08/2007 |
124-58-3 |
|
NAPHTHALENE |
Inh. |
Chr. |
0.0007 ppm |
300 |
Resp. |
Final |
08/2005 |
91-20-3 |
Oral |
Acute |
0.6 mg/kg/day |
90 |
Neurol. |
Final |
08/2005 |
91-20-3 |
Oral |
Int. |
0.6 mg/kg/day |
90 |
Neurol. |
Final |
08/2005 |
91-20-3 |
|
NICKEL |
Inh. |
Int. |
0.0002 mg/m3 |
30 |
Resp. |
Final |
08/2005 |
7440-02-0 |
Inh. |
Chr. |
0.00009 mg/m3 |
30 |
Resp. |
Final |
08/2005 |
7440-02-0 |
|
NITRATE |
Oral |
Acute |
4 mg/kg/day |
1 |
Hemato. |
Final |
07/2017 |
14797-55-8 |
Oral |
Int. |
4 mg/kg/day |
1 |
Hemato. |
Final |
07/2017 |
14797-55-8 |
Oral |
Chr. |
4 mg/kg/day |
1 |
Hemato. |
Final |
07/2017 |
14797-55-8 |
|
NITRITE |
Oral |
Acute |
0.1 mg/kg/day |
2 |
Hemato. |
Final |
07/2017 |
14797-65-0 |
Oral |
Int. |
0.1 mg/kg/day |
2 |
Hemato. |
Final |
07/2017 |
14797-65-0 |
Oral |
Chr. |
0.1 mg/kg/day |
2 |
Hemato. |
Final |
07/2017 |
14797-65-0 |
|
NITROBENZENE |
Inh. |
Acute |
0.04 ppm |
90 |
Hemato. |
Draft |
04/2022 |
98-95-3 |
Inh. |
Int. |
3 ppb |
300 |
Hemato. |
Draft |
04/2022 |
98-95-3 |
Inh. |
Chr. |
1 ppb |
30 |
Resp. |
Draft |
04/2022 |
98-95-3 |
Oral |
Acute |
0.05 mg/kg/day |
100 |
Hemato. |
Draft |
04/2022 |
98-95-3 |
Oral |
Int. |
0.02 mg/kg/day |
100 |
Hemato. |
Draft |
04/2022 |
98-95-3 |
|
N-NITROSODIMETHYLAMINE (NDMA) |
Oral |
Acute |
0.01 ug/kg/day |
100 |
Hemato. |
Draft |
01/2022 |
62-75-9 |
|
1,2,3,7,8-PENTACHLORODIBENZOFURAN |
Oral |
Int. |
7 ng/kg/day |
100 |
Hepatic |
Draft |
01/2022 |
57117-41-6 |
|
2,3,4,7,8-PENTACHLORODIBENZOFURAN |
Oral |
Acute |
0.5 ng/kg/day |
1000 |
Develop. |
Draft |
01/2022 |
57117-31-4 |
Oral |
Int. |
7 pg/kg/day |
100 |
Endocrine |
Draft |
01/2022 |
57117-31-4 |
Oral |
Chr. |
4 pg/kg/day |
1000 |
Hepatic, Endocrine |
Draft |
01/2022 |
57117-31-4 |
|
PARATHION |
Inh. |
Int. |
20 ng/m3 |
100 |
Neurol. |
Final |
01/2017 |
56-38-2 |
Oral |
Int. |
0.009 mg/kg/day |
10 |
Neurol. |
Final |
01/2017 |
56-38-2 |
|
PBDE, DECABROMINATED |
Oral |
Acute |
0.01 mg/kg/day |
100 |
Develop. |
Final |
03/2017 |
67774-32-7 |
Oral |
Int. |
0.0002 mg/kg/day |
300 |
Endocr. |
Final |
03/2017 |
67774-32-7 |
|
PENTACHLOROPHENOL |
Oral |
Acute |
5 ug/kg/day |
1000 |
Develop. |
Final |
04/2022 |
87-86-5 |
Oral |
Chr. |
5 ug/kg/day |
300 |
Hepatic |
Final |
04/2022 |
87-86-5 |
|
PERCHLORATES |
Oral |
Chr. |
0.0007 mg/kg/day |
10 |
Endocr. |
Final |
09/2008 |
14797-73-0 |
|
PERFLUOROHEXANE SULFONIC ACID (PFHxS) |
Oral |
Int. |
0.02 ug/kg/day |
300 |
Endocr. |
Final |
03/2020 |
355-46-4 |
|
PERFLUORONONANOIC ACID (PFNA) |
Oral |
Int. |
3 ng/kg/day |
300 |
Develop. |
Final |
03/2020 |
375-95-1 |
|
PERFLUOROOCTANE SULFONIC ACID (PFOS) |
Oral |
Int. |
2 ng/kg/day |
300 |
Develop. |
Final |
03/2020 |
1763-23-1 |
|
PERFLUOROOCTANOIC ACID (PFOA) |
Oral |
Int. |
3 ng/kg/day |
300 |
Develop. |
Final |
03/2020 |
335-67-1 |
|
PERMETHRIN |
Oral |
Acute |
0.3 mg/kg/day |
100 |
Neurol. |
Final |
09/2003 |
52645-53-1 |
Oral |
Int. |
0.2 mg/kg/day |
100 |
Neurol. |
Final |
09/2003 |
52645-53-1 |
|
PHENOL |
Oral |
Acute |
1 mg/kg/day |
100 |
Body Wt. |
Final |
09/2008 |
108-95-2 |
|
PHOSPHORUS, WHITE |
Inh. |
Acute |
0.02 mg/m3 |
30 |
Resp. |
Final |
09/1997 |
7723-14-0 |
Oral |
Int. |
0.0002 mg/kg/day |
100 |
Repro. |
Final |
09/1997 |
7723-14-0 |
|
POLYBROMINATED BIPHENYLS (PBBS) |
Oral |
Acute |
0.01 mg/kg/day |
100 |
Endocr. |
Final |
09/2004 |
36355-01-8 |
|
POLYBROMINATED DIPHENYL ETHERS (PBDES), LOWER BROMINATED |
Inh. |
Int. |
0.006 mg/m3 |
90 |
Endocr. |
Final |
03/2017 |
32536-52-0 |
Oral |
Acute |
0.00006 mg/kg/day |
1000 |
Develop. |
Final |
03/2017 |
60348-60-9 |
Oral |
Int. |
0.000003 mg/kg/day |
300 |
Reprod. |
Final |
03/2017 |
5436-43-1 |
|
POLYCHLORINATED BIPHENYLS (PCBs) (Aroclor 1254) |
Oral |
Int. |
0.03 ug/kg/day |
300 |
Neurol. |
Final |
11/2000 |
11097-69-1 |
Oral |
Chr. |
0.02 ug/kg/day |
300 |
Immuno. |
Final |
11/2000 |
11097-69-1 |
|
PROPYLENE GLYCOL |
Inh. |
Int. |
0.009 ppm |
1000 |
Resp. |
Final |
09/1997 |
57-55-6 |
|
PROPYLENE GLYCOL DINITRATE |
Inh. |
Acute |
0.003 ppm |
10 |
Neurol. |
Final |
06/1995 |
6423-43-4 |
Inh. |
Int. |
0.00004 ppm |
1000 |
Hemato. |
Final |
06/1995 |
6423-43-4 |
Inh. |
Chr. |
0.00004 ppm |
1000 |
Hemato. |
Final |
06/1995 |
6423-43-4 |
|
RDX (CYCLONITE) |
Oral |
Acute |
0.2 mg/kg/day |
30 |
Neurol. |
Final |
01/2012 |
121-82-4 |
Oral |
Int. |
0.1 mg/kg/day |
30 |
Neurol. |
Final |
01/2012 |
121-82-4 |
Oral |
Chr. |
0.1 mg/kg/day |
30 |
Neurol. |
Final |
01/2012 |
121-82-4 |
|
REFRACTORY CERAMIC FIBERS |
Inh. |
Chr. |
0.03 fibers/cc |
30 |
Resp. |
Final |
09/2004 |
HZ0900-26-T |
|
S,S,S-TRIBUTYL PHOSPHOROTRITHIOATE (TRIBUFOS) |
Inh. |
Int. |
0.04 mg/m3 |
30 |
Neurol. |
Final |
03/2020 |
78-48-8 |
Oral |
Int. |
0.003 mg/kg/day |
100 |
Neurol. |
Final |
03/2020 |
78-48-8 |
Oral |
Chr. |
0.5 ug/kg/day |
100 |
Gastro. |
Final |
03/2020 |
78-48-8 |
|
SELENIUM |
Oral |
Chr. |
0.005 mg/kg/day |
3 |
Dermal |
Final |
09/2003 |
7782-49-2 |
|
STRONTIUM |
Oral |
Int. |
2 mg/kg/day |
90 |
Musculo. |
Final |
04/2004 |
7440-24-6 |
|
STYRENE |
Inh. |
Acute |
5 ppm |
10 |
Neurol. |
Final |
11/2010 |
100-42-5 |
Inh. |
Chr. |
0.2 ppm |
30 |
Neurol. |
Final |
11/2010 |
100-42-5 |
Oral |
Acute |
0.1 mg/kg/day |
1000 |
Neurol. |
Final |
11/2010 |
100-42-5 |
|
SULFUR DIOXIDE |
Inh. |
Acute |
0.01 ppm |
9 |
Resp. |
Final |
12/1998 |
7446-09-5 |
|
SULFUR MUSTARD |
Inh. |
Acute |
0.0007 mg/m3 |
30 |
Ocular |
Final |
09/2003 |
505-60-2 |
Inh. |
Int. |
0.00002 mg/m3 |
30 |
Ocular |
Final |
09/2003 |
505-60-2 |
Oral |
Acute |
0.5 µg/kg/day |
1000 |
Develop. |
Final |
09/2003 |
505-60-2 |
Oral |
Int. |
0.07 µg/kg/day |
300 |
Gastro. |
Final |
09/2003 |
505-60-2 |
|
1,1,1-TRICHLOROETHANE |
Inh. |
Acute |
2 ppm |
100 |
Neurol. |
Final |
07/2006 |
71-55-6 |
Inh. |
Int. |
0.7 ppm |
100 |
Neurol. |
Final |
07/2006 |
71-55-6 |
Oral |
Int. |
20 mg/kg/day |
100 |
Body Wt. |
Final |
07/2006 |
71-55-6 |
|
1,1,2,2-TETRACHLOROETHANE |
Oral |
Int. |
0.5 mg/kg/day |
100 |
Hepatic |
Final |
09/2008 |
79-34-5 |
|
1,1,2-TRICHLOROETHANE |
Inh. |
Acute |
0.03 ppm |
270 |
Resp. |
Final |
03/2021 |
79-00-5 |
Inh. |
Int. |
2 ppb |
30 |
Resp. |
Final |
03/2021 |
79-00-5 |
Oral |
Acute |
0.5 mg/kg/day |
100 |
Hepatic |
Final |
03/2021 |
79-00-5 |
Oral |
Int. |
0.04 mg/kg/day |
100 |
Immuno. |
Final |
03/2021 |
79-00-5 |
|
1,2,3-TRICHLOROPROPANE |
Inh. |
Acute |
1 ppb |
30 |
Resp. |
Final |
08/2021 |
96-18-4 |
Oral |
Int. |
0.03 mg/kg/day |
100 |
Hemato. |
Final |
08/2021 |
96-18-4 |
Oral |
Chr. |
0.01 mg/kg/day |
100 |
Hepatic |
Final |
08/2021 |
96-18-4 |
|
1,2,4 - TRICHLOROBENZENE |
Oral |
Int. |
0.1 mg/kg/day |
100 |
Hepatic |
Final |
10/2014 |
120-82-1 |
Oral |
Chr. |
0.1 mg/kg/day |
100 |
Hepatic |
Final |
10/2014 |
120-82-1 |
|
2,3,4,6-TETRACHLOROPHENOL |
Oral |
Acute |
0.08 mg/kg/day |
100 |
Hepatic |
Final |
06/2022 |
58-90-2 |
Oral |
Int. |
0.01 mg/kg/day |
100 |
Hepatic |
Final |
06/2022 |
58-90-2 |
|
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Oral |
Acute |
0.0002 ug/kg/day |
21 |
Immuno. |
Final |
12/1998 |
1746-01-6 |
Oral |
Int. |
0.00002 ug/kg/day |
30 |
Lymphor. |
Final |
12/1998 |
1746-01-6 |
Oral |
Chr. |
0.000001 ug/kg/day |
90 |
Develop. |
Final |
12/1998 |
1746-01-6 |
|
2,4,5-TRICHLOROPHENOL |
Oral |
Int. |
1 mg/kg/day |
100 |
Hepatic,Renal |
Final |
06/2022 |
95-95-4 |
|
2,4,6-TRICHLOROPHENOL |
Oral |
Int. |
5 ug/kg/day |
100 |
Hepatic |
Final |
06/2022 |
88-06-2 |
|
2,4,6-TRINITROTOLUENE |
Oral |
Int. |
0.0005 mg/kg/day |
1000 |
Hepatic |
Final |
06/1995 |
118-96-7 |
|
TETRACHLOROETHYLENE |
Inh. |
Acute |
0.006 ppm |
300 |
Neurol. |
Final |
06/2019 |
127-18-4 |
Inh. |
Int. |
0.006 ppm |
300 |
Neurol. |
Final |
06/2019 |
127-18-4 |
Inh. |
Chr. |
0.006 ppm |
300 |
Neurol. |
Final |
06/2019 |
127-18-4 |
Oral |
Acute |
0.008 mg/kg/day |
300 |
Neurol. |
Final |
06/2019 |
127-18-4 |
Oral |
Int. |
0.008 mg/kg/day |
300 |
Neurol. |
Final |
06/2019 |
127-18-4 |
Oral |
Chr. |
0.008 mg/kg/day |
300 |
Neurol. |
Final |
06/2019 |
127-18-4 |
|
TIN, DIBUTYL-, DICHLORIDE |
Oral |
Int. |
0.005 mg/kg/day |
1000 |
Immuno. |
Final |
08/2005 |
683-18-1 |
|
TIN, INORGANIC |
Oral |
Int. |
0.3 mg/kg/day |
100 |
Hemato. |
Final |
08/2005 |
7440-31-5 |
|
TIN, TRIBUTYL-, OXIDE |
Oral |
Int. |
0.0003 mg/kg/day |
100 |
Immuno. |
Final |
08/2005 |
56-35-9 |
Oral |
Chr. |
0.0003 mg/kg/day |
100 |
Immuno. |
Final |
08/2005 |
56-36-9 |
|
TITANIUM TETRACHLORIDE |
Inh. |
Int. |
0.01 mg/m3 |
90 |
Resp. |
Final |
09/1997 |
7550-45-0 |
Inh. |
Chr. |
0.0001 mg/m3 |
90 |
Resp. |
Final |
09/1997 |
7550-45-0 |
|
TOLUENE |
Inh. |
Acute |
2 ppm |
9 |
Neurol. |
Final |
06/2017 |
108-88-3 |
Inh. |
Chr. |
1 ppm |
10 |
Neurol. |
Final |
06/2017 |
108-88-3 |
Oral |
Acute |
0.8 mg/kg/day |
300 |
Neurol. |
Final |
06/2017 |
108-88-3 |
Oral |
Int. |
0.2 mg/kg/day |
100 |
Immuno. |
Final |
06/2017 |
108-88-3 |
|
TOLUENE DIISOCYANATE (TDI) |
Inh. |
Acute |
0.00001 ppm |
100 |
Resp. |
Final |
06/2018 |
26471-62-5 |
Inh. |
Chr. |
0.000003 ppm |
100 |
Resp. |
Final |
06/2020 |
26471-62-5 |
|
TOXAPHENE |
Oral |
Acute |
0.05 mg/kg/day |
100 |
Neurol. |
Final |
10/2014 |
8001-35-2 |
Oral |
Int. |
0.002 mg/kg/day |
100 |
Immuno. |
Final |
10/2014 |
8001-35-2 |
|
TRIBUTYL PHOSPHATE (TNBP) |
Oral |
Acute |
1.1 mg/kg/day |
100 |
Body Wt. |
Final |
09/2012 |
126-73-8 |
Oral |
Int. |
0.08 mg/kg/day |
100 |
Renal |
Final |
09/2012 |
126-73-8 |
Oral |
Chr. |
0.08 mg/kg/day |
100 |
Renal |
Final |
09/2012 |
126-73-8 |
|
TRICHLOROETHYLENE |
Inh. |
Int. |
0.0004 ppm |
10 |
Develop. |
Final |
06/2019 |
79-01-6 |
|
|
|
100 |
Immuno. |
|
|
|
Inh. |
Chr. |
0.0004 ppm |
10 |
Develop. |
Final |
06/2019 |
79-01-6 |
|
|
|
100 |
Immuno. |
|
|
|
Oral |
Int. |
0.0005 mg/kg/day |
10 |
Develop. |
Final |
06/2019 |
79-01-6 |
|
|
|
100 |
Immuno. |
|
|
|
|
|
|
1000 |
Immuno. |
|
|
|
Oral |
Chr. |
0.0005 mg/kg/day |
10 |
Develop. |
Final |
06/2019 |
79-01-6 |
|
|
|
100 |
Immuno. |
|
|
|
|
|
|
1000 |
Immuno. |
|
|
|
|
TRICRESYL PHOSPHATE (TCP) |
Oral |
Int. |
0.04 mg/kg/day |
100 |
Reprod. |
Final |
09/2012 |
1330-78-5 |
Oral |
Chr. |
0.02 mg/kg/day |
100 |
Reprod. |
Final |
09/2012 |
1330-78-5 |
|
TRIS(1,3-DICHLORO-2-PROPYL) PHOSPHATE (TDCP) |
Oral |
Int. |
0.05 mg/kg/day |
100 |
Renal |
Final |
09/2012 |
13674-87-8 |
Oral |
Chr. |
0.02 mg/kg/day |
100 |
Renal |
Final |
09/2012 |
13674-87-8 |
|
TRIS(2-BUTOXYETHYL) PHOSPHATE (TBEP) |
Oral |
Acute |
4.8 mg/kg/day |
100 |
Body Wt. |
Final |
09/2012 |
78-51-3 |
Oral |
Int. |
0.09 mg/kg/day |
100 |
Hepatic |
Final |
09/2012 |
78-51-3 |
|
TRIS(2-CHLOROETHYL) PHOSPHATE (TCEP) |
Oral |
Int. |
0.6 mg/kg/day |
100 |
Neurol. |
Final |
09/2012 |
115-96-8 |
Oral |
Chr. |
0.2 mg/kg/day |
100 |
Renal |
Final |
09/2012 |
115-96-8 |
|
URANIUM, INSOLUBLE COMPOUNDS |
Inh. |
Int. |
0.002 mg/m3 |
100 |
Renal |
Final |
02/2013 |
7440-61-1 |
Inh. |
Chr. |
0.0008 mg/m3 |
1000 |
Resp. |
Final |
02/2013 |
7440-61-1 |
|
URANIUM, SOLUBLE SALTS |
Inh. |
Int. |
0.0001 mg/m3 |
300 |
Renal |
Final |
02/2013 |
7440-61-1 |
Inh. |
Chr. |
0.00004 mg/m3 |
100 |
Renal |
Final |
02/2013 |
7440-61-1 |
Oral |
Acute |
0.002 mg/kg/day |
100 |
Develop. |
Final |
02/2013 |
7440-61-1 |
Oral |
Int. |
0.0002 mg/kg/day |
300 |
Renal |
Final |
02/2013 |
7440-61-1 |
|
VANADIUM |
Inh. |
Acute |
0.0008 mg/m3 |
90 |
Resp. |
Final |
09/2012 |
7440-62-2 |
Inh. |
Chr. |
0.0001 mg/m3 |
30 |
Resp. |
Final |
09/2012 |
7440-62-2 |
Oral |
Int. |
0.01 mg/kg/day |
10 |
Hemato. |
Final |
09/2012 |
7440-62-2 |
|
VINYL ACETATE |
Inh. |
Int. |
0.01 ppm |
100 |
Resp. |
Final |
07/1992 |
108-05-4 |
|
VINYL CHLORIDE |
Inh. |
Acute |
0.5 ppm |
30 |
Develop. |
Final |
07/2006 |
75-01-4 |
Inh. |
Int. |
0.03 ppm |
30 |
Hepatic |
Final |
07/2006 |
75-01-4 |
Oral |
Chr. |
0.003 mg/kg/day |
30 |
Hepatic |
Final |
07/2006 |
75-01-4 |
|
XYLENES, MIXED |
Inh. |
Acute |
2 ppm |
30 |
Neurol. |
Final |
08/2007 |
1330-20-7 |
Inh. |
Int. |
0.6 ppm |
90 |
Neurol. |
Final |
08/2007 |
1330-20-7 |
Inh. |
Chr. |
0.05 ppm |
300 |
Neurol. |
Final |
08/2007 |
1330-20-7 |
Oral |
Acute |
1 mg/kg/day |
100 |
Neurol. |
Final |
08/2007 |
1330-20-7 |
Oral |
Int. |
0.4 mg/kg/day |
1000 |
Neurol. |
Final |
08/2007 |
1330-20-7 |
Oral |
Chr. |
0.2 mg/kg/day |
1000 |
Neurol. |
Final |
08/2007 |
1330-20-7 |
|
ZINC |
Oral |
Int. |
0.3 mg/kg/day |
3 |
Hemato. |
Final |
08/2005 |
7440-66-6 |
Oral |
Chr. |
0.3 mg/kg/day |
3 |
Hemato. |
Final |
08/2005 |
7440-66-6 |